Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders-Reference-Cited by-同舟云学术

Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders

Published:2015-01-24 Issue:2 Volume:30 Page:329-336
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Chang Ming-Ling¹²,Hsu Chen-Ming¹,Tseng Jeng-Hwei³,Tsou Yung-Kuan¹,Chen Shu-Chun¹,Shiau Shuen-Shian¹,Yeh Chau-Ting¹²,Chiu Cheng-Tang¹

Affiliation:

1. Liver Research Centre and Division of Hepatology; Department of Gastroenterology and Hepatology; Chang Gung Memorial Hospital; Linkou Taiwan

2. Graduate Institute of Clinical Medical Sciences; College of Medicine; Chang Gung University; Taoyuan Taiwan

3. Department of Medical Imaging and Intervention; Chang Gung Memorial Hospital at Linkou; Chang Gung University College of Medicine; Taoyuan Taiwan

Funder

Chang Gung Medical Research Program

National Science Council of Taiwan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12705/fullpdf

Reference48 articles.

1. Nonalcoholic fatty liver disease;Angulo;N. Engl. J. Med.,2002

2. Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in nonalcoholic fatty liver disease;Schäffler;Nat. Clin. Pract. Gastroenterol. Hepatol.,2005

3. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States;Ruhl;Gastroenterology,2003

4. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue;Yu;Circ. Res.,2005

5. Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis;Tilg;Curr. Pharm. Des.,2010

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter: Role of Helicobacter pylori and metabolic syndrome‐related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH;Alimentary Pharmacology & Therapeutics;2024-07-30

2. Insight into increased risk of portal vein thrombosis in nonalcoholic fatty liver disease;European Journal of Internal Medicine;2023-08

3. SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups;World Journal of Gastroenterology;2023-04-28

4. Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?;World Journal of Gastroenterology;2023-01-14

5. Plasminogen Activator Inhibitor-1 Levels in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis;Journal of Gastrointestinal and Liver Diseases;2022-06-12